arrow
A

Anzaan Dippenaar

University of Antwerp
H指数:24
被引数:2,110

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Whole genome sequencing precision medicine strategy to shorten treatment for rifampicin-resistant tuberculosis (SMARTT): a pragmatic, randomised, single-blind phase 4 trial

缩短利福平耐药结核病治疗时间的全基因组测序精准医学策略 (SMARTT): 一项实用、随机、单盲4期试验

2026-04-200
PRE
Whole-genome sequencing reveals genetic diversity and transmission dynamics of Mycobacterium bovis in South African wildlife

全基因组测序揭示南非野生动物中牛分枝杆菌的遗传多样性和传播动态

2026-02-010
PRE
Targeted and whole-genome sequencing for drug resistance and genetic relatedness inference of rifampicin-resistant Mycobacterium tuberculosis: an in-depth comparison

靶向测序和全基因组测序在利福平耐药结核分枝杆菌的耐药性和遗传相关性推断中的应用:深入比较

2026-01-010
PRE
Undetected rifampicin-resistant tuberculosis associated with rpoB I491F and V170F mutations in Botswana: diagnostic implications

未检测到的利福平耐药结核病与博茨瓦纳rpoB I491F和V170F突变的关联:诊断意义

2025-12-120
OAAI
Whole genomic analysis uncovers high genetic diversity of rifampicin-resistant Mycobacterium tuberculosis strains in Botswana
2025-02-110
OAAI
Bridging the gap between molecular and genomic epidemiology in tuberculosis: inferring MIRU-VNTR patterns from genomic data
2024-09-110
PRE
A Genome-Focused Investigation Reveals the Emergence of a Mycobacterium tuberculosis Strain Related to Multidrug-Resistant Tuberculosis in the Amazon Region of Brazil

以基因组为重点的调查揭示了与巴西亚马逊地区耐多药结核病相关的结核分枝杆菌菌株的出现

2024-09-021
OAAI
Whole-Genome Sequencing Has the Potential To Improve Treatment for Rifampicin-Resistant Tuberculosis in High-Burden Settings: a Retrospective Cohort Study

全基因组测序有可能改善高负荷地区耐利福平结核病的治疗: 一项回顾性队列研究

2022-03-1618
OAAI
Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid

结核分枝杆菌复合体对pretomanid的内在敏感性的古代和近期差异

2022-03-0942
OAAI